Ratain MJ - Search Results

1

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.

Quintanilha JCF, Wang J, Sibley AB, Jiang C, Etheridge AS, Shen F, Jiang G, Mulkey F, Patel JN, Hertz DL, Dees EC, McLeod HL, Bertagnolli M, Rugo H, Kindler HL, Kelly WK, Ratain MJ, Kroetz DL, Owzar K, Schneider BP, Lin D, Innocenti F. Quintanilha JCF, et al. Among authors: ratain mj. Br J Cancer. 2022 Feb;126(2):265-274. doi: 10.1038/s41416-021-01557-w. Epub 2021 Oct 6. Br J Cancer. 2022. PMID: 34616010 Free PMC article. Clinical Trial.

2

Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

Schilsky RL, Bertucci D, Vogelzang NJ, Kindler HL, Ratain MJ. Schilsky RL, et al. Among authors: ratain mj. J Clin Oncol. 2002 Jan 15;20(2):582-7. doi: 10.1200/JCO.2002.20.2.582. J Clin Oncol. 2002. PMID: 11786589 Clinical Trial.

3

Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.

Mani S, Rudin CM, Kunkel K, Holmlund JT, Geary RS, Kindler HL, Dorr FA, Ratain MJ. Mani S, et al. Among authors: ratain mj. Clin Cancer Res. 2002 Apr;8(4):1042-8. Clin Cancer Res. 2002. PMID: 11948111 Clinical Trial.

4

Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Clin Cancer Res. 2002 May;8(5):1314; author reply 1315-6. Clin Cancer Res. 2002. PMID: 12006555 No abstract available.

5

In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.

Ramírez J, Iyer L, Journault K, Bélanger P, Innocenti F, Ratain MJ, Guillemette C. Ramírez J, et al. Among authors: ratain mj. Pharm Res. 2002 May;19(5):588-94. doi: 10.1023/a:1015341726183. Pharm Res. 2002. PMID: 12069159

6

Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism.

Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain MJ. Liu W, et al. Among authors: ratain mj. Clin Cancer Res. 2003 Mar;9(3):1009-12. Clin Cancer Res. 2003. PMID: 12631599

7

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR. Akerley W, et al. Among authors: ratain mj. Cancer. 2003 May 15;97(10):2480-6. doi: 10.1002/cncr.11375. Cancer. 2003. PMID: 12733147 Free article. Clinical Trial.

8

Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Oncology (Williston Park). 2003 May;17(5 Suppl 5):52-5. Oncology (Williston Park). 2003. PMID: 12800608 Review.

9

UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Among authors: ratain mj. Pharmacogenetics. 2003 Aug;13(8):517-23. doi: 10.1097/01.fpc.0000054116.14659.e5. Pharmacogenetics. 2003. PMID: 12893990

10

Pharmacogenomics: road to anticancer therapeutics nirvana?

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Among authors: ratain mj. Oncogene. 2003 Sep 29;22(42):6621-8. doi: 10.1038/sj.onc.1206958. Oncogene. 2003. PMID: 14528287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters